Adagene (ADAG) Total Current Liabilities (2019 - 2026)
Adagene (ADAG) posted quarterly Total Current Liabilities of $25172.1 billion for Q4 2025, down 34.08% year-over-year from $38184.9 billion in Q4 2024, and up 88272715.97% quarter-over-quarter from $28.5 million in Q2 2025.
Adagene (ADAG) Total Current Liabilities (2019 - 2026) Analysis & Trends
Adagene (ADAG) has reported Total Current Liabilities for 7 consecutive years, with $25172.1 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Current Liabilities fell 34.08% year-over-year to $25172.1 billion; the TTM figure through Dec 2025 stood at $25172.1 billion (down 34.08% YoY), while the FY2025 annual figure was $25172.1 billion, down 34.08% from the prior year.
- Total Current Liabilities rose to $25172.1 billion in Q4 2025 per ADAG's latest filing, from $28.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $56455.1 billion in Q2 2022 and bottomed at $28.5 million in Q2 2025.
- Historically, Total Current Liabilities has averaged $24534.0 billion across 5 years, with a median of $28313.9 billion in 2023.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 190877015.16% — and 2024, when it sank 100.0%.
- Adagene's Total Current Liabilities stood at $29.8 million in 2021, then jumped by 184697642.74% to $55080.4 billion in 2022, then slumped by 42.89% to $31455.6 billion in 2023, then rose by 21.39% to $38184.9 billion in 2024, then tumbled by 34.08% to $25172.1 billion in 2025.
- Business Quant data shows ADAG's Total Current Liabilities at $25172.1 billion in Q4 2025, $28.5 million in Q2 2025, and $38184.9 billion in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Adagene | 310.54 Mn | 310.54 Mn | - | 26.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.36 Mn |
| Dec 31, 2025 | 25,172.10 Bn |
| Jun 30, 2025 | 28.52 Mn |
| Dec 31, 2024 | 38,184.94 Bn |
| Jun 30, 2024 | 39.52 Mn |
| Dec 31, 2023 | 31,455.65 Bn |
| Jun 30, 2023 | 38,991.62 Bn |
| Dec 31, 2022 | 55,080.40 Bn |
| Jun 30, 2022 | 56,455.10 Bn |
| Dec 31, 2021 | 29.82 Mn |
| Jun 30, 2021 | 29.58 Mn |
| Dec 31, 2020 | 16.15 Mn |
| Dec 31, 2019 | 7.18 Mn |